SOLID BIOSCIENCES INC. 25,000,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • March 19th, 2021 • Solid Biosciences Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 19th, 2021 Company Industry JurisdictionSolid Biosciences Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 21,739,131 shares of common stock, par value $0.001 per share, of the Company (the “Underwritten Shares”), and, at the option of the Underwriters, up to an additional 3,260,869 shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”